Philadelphia Pharmaceuticals Company (ASE:PHIL)

ASE:PHIL Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	12	12	11	11	10	10
Market Cap Growth	13.14%	6.67%	4.90%	2.88%	1.46%	-4.20%
Enterprise Value	12	12	12	11	11	11
Last Close Price	1.55	1.60	1.43	1.30	1.21	1.14
PE Ratio	11.57	11.94	13.69	13.29	14.87	25.05
PS Ratio	1.27	1.31	1.28	1.28	1.24	1.56
PB Ratio	0.86	0.89	0.86	0.84	0.84	0.85
P/TBV Ratio	1.13	1.17	0.86	0.84	0.84	1.06
P/FCF Ratio	10.08	10.40	7.37	10.37	5.37	3.49
P/OCF Ratio	8.47	8.75	6.54	9.75	4.95	3.27
EV/Sales Ratio	1.26	1.35	1.36	1.36	1.28	1.66
EV/EBITDA Ratio	5.58	5.97	7.13	6.94	8.83	12.45
EV/EBIT Ratio	7.52	8.04	8.53	8.45	9.79	15.22
EV/FCF Ratio	10.02	10.72	7.80	11.07	5.54	3.72
Debt / Equity Ratio	0.13	0.13	0.15	0.12	0.15	0.12
Debt / EBITDA Ratio	0.85	0.85	1.19	0.90	1.50	1.65
Debt / FCF Ratio	1.53	1.53	1.30	1.44	0.94	0.49
Net Debt / Equity Ratio	0.00	0.00	0.03	0.01	0.03	-0.02
Net Debt / EBITDA Ratio	-0.03	-0.03	0.20	0.06	0.27	-0.24
Net Debt / FCF Ratio	-0.06	-0.06	0.22	0.09	0.17	-0.07
Asset Turnover	0.54	0.54	0.54	0.53	0.55	0.44
Inventory Turnover	2.24	2.24	2.45	2.66	2.93	1.83
Quick Ratio	2.79	2.79	2.88	2.39	2.27	2.87
Current Ratio	3.72	3.72	3.67	3.08	2.73	3.48
Return on Equity (ROE)	7.57%	7.57%	6.37%	6.42%	5.72%	3.48%
Return on Assets (ROA)	5.67%	5.67%	5.34%	5.32%	4.44%	2.99%
Return on Invested Capital (ROIC)	9.00%	9.06%	8.42%	8.38%	7.22%	5.10%
Return on Capital Employed (ROCE)	10.80%	10.80%	10.10%	10.60%	8.90%	5.90%
Earnings Yield	8.65%	8.38%	7.30%	7.53%	6.73%	3.99%
FCF Yield	9.92%	9.61%	13.57%	9.64%	18.62%	28.63%
Dividend Yield	4.52%	-	4.89%	5.38%	4.96%	5.26%
Payout Ratio	52.23%	52.23%	63.91%	55.75%	64.18%	-
Total Shareholder Return	4.52%	-	4.89%	5.38%	4.96%	5.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.